Filing search / Intellia Therapeutics, Inc. / "Supply Chain"

Search information

Intellia Therapeutics, Inc.

Companies

"Supply Chain"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

31 results

Newest first Best match first

10-K

2024 FY

EX-19.1

NTLA Intellia Therapeutics, Inc.

Annual report

or internal investigations. Patent related events. Changes in top management. Significant issues with 3rd party vendor performance or delays in supply … chain. Cyber related incidents. Any other event or circumstance deemed Material Nonpublic Information by the GC in consultation with the CEO and CFO

27 Feb 25

4:03pm

DEF 14A

NTLA Intellia Therapeutics, Inc.

Definitive proxy

, cash equivalents and marketable securities. We continued to secure supply chain and relevant materials and systems to support our current

29 Apr 24

4:16pm

PRE 14A

NTLA Intellia Therapeutics, Inc.

Preliminary proxy

supply chain and relevant materials and systems to support our current and projected clinical trials for our in vivo and ex vivo therapies. We continue

16 Apr 24

4:10pm

10-Q

2023 Q2

EX-10.1

NTLA Intellia Therapeutics, Inc.

Quarterly report

acknowledge and agree that (w) as of the date of this Lease there exist significant global supply chain delays and shortages of construction materials … , supplies and equipment (collectively, “Supply Chain Delays”), (x) the availability of fixtures, equipment and/or materials required for the performance

3 Aug 23

4:13pm

10-Q

2023 Q1

NTLA Intellia Therapeutics, Inc.

Quarterly report

and laboratories, or to pause or suspend preclinical research and our clinical trial; and, further, may disrupt our manufacturing and supply chain

4 May 23

4:12pm

DEF 14A

mv0fzcfl

Definitive proxy

1 May 23

4:21pm

Prospectus supplement for primary offering

3 Nov 22

4:03pm

Regulation FD Disclosure

4 Aug 22

4:04pm

Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of

5 May 22

12:00am

DEF 14A

eadbxhhpo12rgb2i5

Definitive proxy

2 May 22

4:31pm

424B5

m8n072bkofy o1a9so

4 Mar 22

Prospectus supplement for primary offering

24 Feb 22

4:22pm

24 Feb 22

4:22pm

10-Q

xvq3f9

Quarterly report

4 Nov 21

4:32pm

10-Q

doc eovg358e

Quarterly report

5 Aug 21

4:47pm

424B5

81l2ndzurx85 e19

1 Jul 21

Prospectus supplement for primary offering

4:55pm

Filing search / Intellia Therapeutics, Inc. / "Supply Chain"

31 results

Top filers

Top filing types

Recent filing years